Archimedes Pharma announces major fundraising of £65 million
Appoints new Chief Executive Officer to accelerate growth of transatlantic business
03-Mar-2010 -
Archimedes Pharma announced that it has raised £65 million (approx US$100 million) in new funding. The round was led by new investor Novo Growth Equity, the growth equity fund of Novo A/S, and included participation by major current investor, Warburg Pincus, a global private equity firm. ...
cancer pain
dosing
drug development
+7